These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3977846)

  • 1. Comparison of the behaviour in vivo of two molecular forms of antithrombin III.
    Carlson TH; Atencio AC; Simon TL
    Biochem J; 1985 Feb; 225(3):557-64. PubMed ID: 3977846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo behavior of radioiodinated rabbit antithrombin III. Demonstration of a noncirculating vascular compartment.
    Carlson TH; Atencio AC; Simon TL
    J Clin Invest; 1984 Jul; 74(1):191-9. PubMed ID: 6376543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo behavior of human radioiodinated antithrombin III: distribution among three physiologic pools.
    Carlson TH; Simon TL; Atencio AC
    Blood; 1985 Jul; 66(1):13-9. PubMed ID: 4005426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative metabolism and distribution of rabbit heparin cofactor II and rabbit antithrombin in rabbits.
    Hatton MW; Hoogendoorn H; Southward SM; Ross B; Blajchman MA
    Am J Physiol; 1997 May; 272(5 Pt 1):E824-31. PubMed ID: 9176182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.
    Collen D; Schetz J; de Cock F; Holmer E; Verstraete M
    Eur J Clin Invest; 1977 Feb; 7(1):27-35. PubMed ID: 65284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin on the vascular distribution of *I-antithrombin III isoforms in rabbits.
    Carlson TH
    Thromb Res; 1989 Aug; 55(4):471-80. PubMed ID: 2814938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catabolism of rabbit prothrombin in rabbits: uptake of prothrombin by the aorta wall before and after a de-endothelializing injury in vivo.
    Hatton MW; Southward SM; Serebrin SD; Kulczycky M; Blajchman MA
    J Lab Clin Med; 1995 Dec; 126(6):521-9. PubMed ID: 7490511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative catabolism of prothrombin and antithrombin in normal and alloxan-diabetic rabbits.
    Hatton MW; Southward SM; Blajchman MA; Ross B; Winocour PD; Richardson M
    Metabolism; 1997 Dec; 46(12):1406-11. PubMed ID: 9439534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution of covalent antithrombin-heparin complexes.
    Chindemi PA; Klement P; Konecny F; Berry LR; Chan AK
    Thromb Haemost; 2006 Apr; 95(4):629-36. PubMed ID: 16601833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and partial characterization of two distinct types of antithrombin III from rabbit.
    Carlson TH; Atencio AC
    Thromb Res; 1982 Jul; 27(1):23-34. PubMed ID: 7123512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catabolism and distribution of functionally heterogeneous human antithrombin III.
    Marciniak E; Romond EH
    J Lab Clin Med; 1987 Jan; 109(1):89-96. PubMed ID: 3794520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of intravenously administered radiolabelled antithrombin III and heparin in humans.
    de Swart CA; Nijmeyer B; Andersson LO; Holmer E; Sixma JJ; Bouma BN
    Thromb Haemost; 1984 Aug; 52(1):66-70. PubMed ID: 6495266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin.
    Chan AK; Paredes N; Thong B; Chindemi P; Paes B; Berry LR; Monagle P
    Thromb Haemost; 2004 May; 91(5):1009-18. PubMed ID: 15116263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M; Holmer E; de Mol M; Collen D
    Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III: biodistribution in healthy volunteers.
    Knot EA; de Jong E; ten Cate JW; Gie LK; van Royen EA
    Thromb Haemost; 1987 Dec; 58(4):1008-11. PubMed ID: 3445222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered levels of antithrombin III and fibrinogen in the aortic wall of the alloxan-induced diabetic rabbit: evidence of a prothrombotic state.
    Witmer MR; Hadcock SJ; Peltier SL; Winocour PD; Richardson M; Hatton MW
    J Lab Clin Med; 1992 Mar; 119(3):221-30. PubMed ID: 1541872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel antithrombin-heparin covalent complex: antithrombotic and bleeding studies in rabbits.
    Chan AK; Berry L; Klement P; Julian J; Mitchell L; Weitz J; Hirsh J; Andrew M
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):587-95. PubMed ID: 9863706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heterogeneity of mammalian antithrombin III].
    Bashkov GV; Kalishevskaia TM; Strukova SM
    Biokhimiia; 1989 Nov; 54(11):1797-803. PubMed ID: 2627551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G
    Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.
    Lollar P; Owen WG
    J Clin Invest; 1980 Dec; 66(6):1222-30. PubMed ID: 6255009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.